Hans Oppitz
Papers
1
Total Citations
3
H-Index
1
About
Hans Oppitz is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for liver metastases. His major contribution lies in the rigorous, long-term characterization of normal tissue changes following high-precision liver irradiation. Through his pivotal multi-institutional pooled analysis, Oppitz provided the first comprehensive MRI-based assessment of morphologic liver alterations years after active motion-compensated SBRT. This work is critical for informing safe, multimodal treatment planning and understanding late radiation effects. While his landmark 2023 study has garnered early citations, his research impact is defined by its foundational role in establishing evidence-based guidelines for liver SBRT. Oppitz’s achievements include spearheading collaborative, multi-center efforts that pool data to achieve statistical power rare in single-institution studies. His research directly addresses a key clinical question: how to balance the curative potential of SBRT against long-term hepatic toxicity. For students and researchers, Oppitz’s work exemplifies the importance of longitudinal, imaging-driven outcomes in advancing personalized radiotherapy, ensuring that aggressive local therapy does not compromise overall liver function and patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1